26/03/2023
Guillain-Barre syndrome (GBS) is a rare autoimmune disorder in which the immune system attacks the peripheral nerves that control muscle movement and sensation.
This leads to weakness, numbness, and tingling in the limbs, which can progress to paralysis in severe cases.
The exact cause of GBS is not fully understood, but it is thought to be triggered by an infection, such as a viral or bacterial infection.
The onset of symptoms can be sudden and may develop over the course of hours or days.
The most common symptoms of GBS include muscle weakness, numbness or tingling in the limbs, and difficulty with coordination and balance.
In some cases, the weakness can progress to the point where the affected person is unable to move or breathe on their own.
Treatment for GBS typically involves supportive care, such as physical therapy and respiratory support, to manage symptoms while the body recovers.
In some cases, plasmapheresis or intravenous immunoglobulin therapy may be used to reduce the severity of the immune response and speed up recovery.
Most people with GBS recover fully or have only minor residual effects, but in rare cases, the condition can be life-threatening.
